Download: Where are we now with US payers on biosimilars pricing, uptake and reimbursement?

      At the Market Access World USA conference held last October 17th in Boston, Ken Walsh, Global Pricing & Market Access, Sandoz Biopharmaceuticals gave a presentation on "Where are We Now with US Payers on Biosimilars Pricing, Uptake and Reimbursement?"  In the presentation, he discusses biosimilars today in the US in light of BCPA / ACA reform, and …